Complete Filing Data
Lyell Immunopharma, Inc. reported Stockholders Equity of $248.20 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Lyell Immunopharma, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenues | $36.0K | $61.0K | $130.0K | $84.7M | $10.7M | $7.8M | $657.0K |
| Other Nonoperating Income Expense | -$18.1M | $4.7M | $1.8M | $1.9M | -$161.0K | $1.5M | -$35.4M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$49.0K | $385.0K | $7.5M | -$6.0M | -$1.9M | -$198.0K | $454.0K |
| Other Comprehensive Income Loss Net Of Tax | -$49.0K | $385.0K | $7.5M | -$6.0M | -$1.9M | -$198.0K | $454.0K |
| Operating Income Loss | -$269.4M | -$358.8M | -$247.0M | -$187.1M | -$214.8M | -$211.9M | -$102.1M |
| Operating Expenses | $269.4M | $358.8M | $247.1M | $271.7M | $225.4M | $219.7M | $102.7M |
| Net Income Loss | -$274.4M | -$343.0M | -$234.6M | -$183.1M | -$250.2M | -$204.5M | -$129.4M |
| General And Administrative Expense | $45.1M | $52.0M | $67.0M | $117.3M | $89.1M | $46.9M | $39.2M |
| Comprehensive Income Net Of Tax | -$274.5M | -$342.6M | -$227.1M | -$189.1M | -$252.1M | -$204.7M | -$128.9M |
| Research And Development Expense | $182.9M | $159.2M | $138.7M | $182.2M | $63.6M | ||
| Nonoperating Income Expense | -$5.0M | $15.8M | $12.4M | $3.9M | -$35.4M | $7.5M | -$27.3M |
| Interest Income Expense Nonoperating Net | $13.1M | $24.1M | $23.5M | $7.1M | $1.2M | $5.9M | $8.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | $15.0K | $8.0K | $7.0K | $34.0K | $13.0K | $3.0K | $25.0K | $27.0K | $65.0K | $3.0K | $35.7M | $553.0K | $2.8M | $2.6M | $2.4M | $1.1M | $3.1M |
| Other Nonoperating Income Expense | -$4.9M | $1.2M | $1.3M | -$43.0K | -$645.0K | $1.1M | $1.6M | -$326.0K | $1.1M | -$1.1M | -$14.0K | $35.0K | $16.0K | -$106.0K | -$27.0K | $28.0K | $29.0K |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $144.0K | -$101.0K | -$133.0K | $1.2M | $7.0K | -$310.0K | $1.2M | $1.5M | $3.7M | -$1.6M | -$1.8M | -$5.0M | -$138.0K | -$90.0K | -$93.0K | -$598.0K | $105.0K |
| Other Comprehensive Income Loss Net Of Tax | $144.0K | -$101.0K | -$133.0K | $1.2M | $7.0K | -$310.0K | $1.2M | $1.5M | $3.7M | -$1.6M | -$1.8M | -$5.0M | -$138.0K | -$90.0K | -$93.0K | -$598.0K | $105.0K |
| Operating Income Loss | -$37.3M | -$47.1M | -$57.4M | -$50.5M | -$51.5M | -$55.6M | -$59.0M | -$65.9M | -$62.6M | -$66.4M | -$37.3M | -$68.6M | -$49.2M | -$62.7M | -$55.4M | -$36.8M | -$102.6M |
| Operating Expenses | $37.3M | $47.1M | $57.4M | $50.5M | $51.5M | $55.6M | $59.1M | $65.9M | $62.6M | $66.4M | $73.0M | $69.1M | $51.9M | $65.3M | $57.8M | $37.9M | $105.7M |
| Net Income Loss | -$38.8M | -$42.7M | -$52.2M | -$44.6M | -$45.8M | -$60.7M | -$50.9M | -$63.9M | -$67.0M | -$70.3M | -$36.3M | -$68.1M | -$48.9M | -$62.6M | -$55.0M | -$35.7M | -$100.7M |
| General And Administrative Expense | $10.7M | $9.8M | $14.0M | $11.8M | $12.3M | $13.5M | $15.5M | $19.0M | $19.3M | $26.1M | $30.5M | $34.4M | $21.2M | $19.1M | $16.8M | $13.6M | $9.6M |
| Comprehensive Income Net Of Tax | -$38.7M | -$42.8M | -$52.3M | -$43.4M | -$45.8M | -$61.0M | -$49.7M | -$62.4M | -$63.2M | -$71.9M | -$38.1M | -$73.1M | -$49.0M | -$62.7M | -$55.1M | -$36.3M | -$100.6M |
| Research And Development Expense | $28.2M | $34.9M | $43.4M | $39.5M | $40.3M | $43.2M | $43.8M | $47.5M | $44.6M | $41.6M | $43.7M | $35.8M | $31.4M | $46.4M | $41.5M | $24.5M | $97.2M |
| Nonoperating Income Expense | -$1.6M | $4.5M | $5.2M | $5.9M | $5.7M | -$5.1M | $8.2M | $2.0M | -$4.4M | -$3.8M | $938.0K | $432.0K | $286.0K | $112.0K | $327.0K | ||
| Interest Income Expense Nonoperating Net | $3.3M | $3.3M | $3.9M | $6.0M | $6.4M | $6.8M | $6.6M | $5.3M | $4.5M | $2.3M | $952.0K | $397.0K | $270.0K | $218.0K | $354.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $248.2M | $382.8M | $655.0M | $833.3M | $929.8M | -$292.5M | -$111.1M | $850.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $61.8M | $107.3M | $145.9M | $123.8M | $294.3M | $140.9M | $98.5M | $130.3M |
| Cash And Cash Equivalents At Carrying Value | $60.2M | $105.6M | $145.6M | $123.6M | $293.8M | $140.4M | $96.7M | |
| Restricted Cash Noncurrent | $1.6M | $1.7M | $284.0K | $280.0K | $466.0K | $466.0K | $1.8M | |
| Fair Value Adjustment Of Success Payment Liabilities | $831.0K | -$1.2M | -$2.8M | -$5.1M | $3.7M | $5.3M | $436.0K | |
| Cash Paid For Amounts Included In Measurement Of Lease Liabilities | $12.6M | $11.5M | $10.8M | $10.9M | $8.5M | $5.1M | $1.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$45.5M | -$38.6M | $22.1M | -$170.5M | $153.4M | $42.4M | -$31.8M | |
| Accretion Amortization Of Discounts And Premiums Investments | $5.0M | $14.7M | $9.6M | $930.0K | -$1.9M | -$539.0K | $1.5M | |
| Equity Securities Fv Ni Unrealized Loss | $0.00 | $13.0M | $12.9M | $5.0M | $36.4M | $0.00 | ||
| Gain Loss On Disposition Of Assets | -$3.3M | -$1.3M | -$1.5M | -$103.0K | -$1.2M | $4.9M | $0.00 | |
| Retained Earnings Accumulated Deficit | -$1.62B | -$1.35B | -$1.00B | -$767.5M | -$584.4M | -$334.1M | ||
| Property Plant And Equipment Net | $34.8M | $48.2M | $102.7M | $123.0M | $120.1M | $77.0M | ||
| Prepaid Expense And Other Assets Current | $13.7M | $9.1M | $8.5M | $11.1M | $11.5M | $4.9M | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Other Liabilities Noncurrent | $517.0K | $3.3M | $3.7M | $4.1M | $4.6M | $532.0K | ||
| Other Investments | $19.0M | $19.0M | $32.0M | $44.9M | $47.0M | $83.4M | ||
| Other Assets Noncurrent | $4.9M | $4.6M | $4.2M | $4.7M | $3.5M | $2.8M | ||
| Operating Lease Right Of Use Asset | $18.9M | $24.7M | $39.7M | $43.2M | $46.5M | $47.0M | ||
| Operating Lease Liability Noncurrent | $41.9M | $51.0M | $56.9M | $63.2M | $66.7M | $51.0M | ||
| Marketable Securities Noncurrent | $0.00 | $13.0M | $16.5M | $70.1M | $283.5M | $80.0M | ||
| Marketable Securities Current | $187.0M | $264.9M | $400.6M | $516.6M | $321.0M | $472.2M | ||
| Liabilities Current | $49.4M | $53.8M | $34.5M | $37.0M | $46.7M | $49.3M | ||
| Liabilities And Stockholders Equity | $340.1M | $490.9M | $750.0M | $937.6M | $1.13B | $908.3M | ||
| Liabilities | $91.9M | $108.0M | $95.1M | $104.3M | $197.6M | $189.8M | ||
| Common Stock Value | $2.0K | $1.0K | $25.0K | $25.0K | $24.0K | $2.0K | ||
| Assets Current | $260.9M | $379.6M | $554.7M | $651.3M | $626.3M | $617.5M | ||
| Assets | $340.1M | $490.9M | $750.0M | $937.6M | $1.13B | $908.3M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $242.0K | $291.0K | -$94.0K | -$7.6M | -$1.6M | $256.0K | ||
| Accrued Liabilities And Other Liabilities | $46.5M | $40.8M | $28.1M | $28.8M | $29.1M | $28.0M | ||
| Accounts Payable Current | $2.9M | $5.4M | $4.8M | $3.9M | $3.2M | $9.4M | ||
| Non Cash Lease Income Expense | $3.6M | $2.2M | $1.9M | $1.6M | -$911.0K | |||
| Cash Received For Amounts Related To Tenant Improvement Allowances | $0.00 | $0.00 | $4.8M | $13.3M | $3.0M | $2.2M | ||
| Success Payment Liabilities Current | $411.0K | $1.6M | $4.4M | $9.5M | $5.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $329.1M | $298.9M | $336.5M | $530.7M | $566.5M | $603.2M | $697.6M | $736.9M | $783.8M | $820.0M | $868.0M | $881.2M | $986.5M | $1.02B | -$334.0M | -$266.6M | -$240.1M | -$150.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $125.2M | $100.4M | $122.0M | $100.6M | $133.7M | $125.9M | $286.5M | $224.7M | $109.7M | $116.6M | $206.0M | $222.9M | $394.0M | $564.9M | $244.8M | $134.9M | $246.4M | |
| Cash And Cash Equivalents At Carrying Value | $123.6M | $98.8M | $120.3M | $100.3M | $133.4M | $125.7M | $286.2M | $224.4M | $109.4M | $116.3M | $205.7M | $222.6M | $393.5M | $564.4M | $244.4M | $134.4M | $246.0M | |
| Restricted Cash Noncurrent | $1.6M | $1.6M | $1.7M | $288.0K | $287.0K | $286.0K | $283.0K | $282.0K | $281.0K | $279.0K | $279.0K | $279.0K | $466.0K | $466.0K | $466.0K | |||
| Fair Value Adjustment Of Success Payment Liabilities | -$125.0K | $968.0K | -$1.7M | -$3.9M | $10.0M | |||||||||||||
| Cash Paid For Amounts Included In Measurement Of Lease Liabilities | $3.1M | $2.7M | $2.4M | $2.7M | $1.4M | |||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $14.7M | -$20.0M | -$14.1M | -$71.4M | $104.0M | |||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $1.7M | $4.4M | $1.9M | -$475.0K | -$483.0K | |||||||||||||
| Equity Securities Fv Ni Unrealized Loss | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $13.0M | $0.00 | $2.9M | $10.0M | $5.0M | $0.00 | $0.00 | ||||||
| Gain Loss On Disposition Of Assets | -$1.3M | -$15.0K | $0.00 | -$84.0K | $0.00 | |||||||||||||
| Retained Earnings Accumulated Deficit | -$1.48B | -$1.44B | -$1.40B | -$1.15B | -$1.11B | -$1.06B | -$949.2M | -$898.3M | -$834.4M | -$759.1M | -$688.8M | -$652.5M | -$500.7M | -$451.8M | ||||
| Property Plant And Equipment Net | $36.7M | $39.1M | $44.2M | $88.0M | $93.1M | $97.8M | $108.1M | $113.7M | $118.6M | $125.7M | $127.6M | $125.7M | $115.9M | $109.6M | ||||
| Prepaid Expense And Other Assets Current | $8.6M | $5.4M | $8.0M | $9.5M | $8.7M | $7.9M | $11.4M | $10.7M | $11.6M | $11.6M | $11.2M | $11.8M | $12.2M | $10.3M | ||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Other Liabilities Noncurrent | $2.7M | $3.0M | $3.1M | $3.6M | $3.4M | $3.6M | $3.8M | $3.9M | $4.0M | $4.2M | $4.3M | $4.5M | $5.0M | $900.0K | ||||
| Other Investments | $19.0M | $19.0M | $19.0M | $19.0M | $19.0M | $19.0M | $32.0M | $32.0M | $34.9M | $42.0M | $47.0M | $47.0M | $83.4M | $83.4M | ||||
| Other Assets Noncurrent | $2.5M | $2.5M | $3.2M | $5.1M | $4.2M | $4.2M | $4.4M | $4.5M | $4.6M | $2.9M | $3.7M | $3.6M | $2.7M | $2.8M | ||||
| Operating Lease Right Of Use Asset | $19.9M | $21.0M | $23.6M | $36.7M | $37.7M | $38.7M | $40.6M | $41.5M | $42.4M | $44.1M | $44.9M | $45.7M | $47.2M | $48.4M | ||||
| Operating Lease Liability Noncurrent | $44.3M | $46.6M | $48.9M | $51.4M | $53.3M | $55.2M | $58.6M | $60.2M | $61.8M | $64.6M | $66.1M | $67.5M | $65.7M | $61.5M | ||||
| Marketable Securities Noncurrent | $0.00 | $20.1M | $28.9M | $20.1M | $0.00 | $0.00 | $22.7M | $37.0M | $55.3M | $102.5M | $131.4M | $224.1M | $317.5M | $150.3M | ||||
| Marketable Securities Current | $196.0M | $178.0M | $180.8M | $340.2M | $357.7M | $400.7M | $289.2M | $371.4M | $503.3M | $531.8M | $449.8M | $391.3M | $225.4M | $260.1M | ||||
| Liabilities Current | $31.9M | $36.9M | $41.3M | $33.5M | $30.9M | $32.4M | $35.1M | $34.4M | $30.8M | $51.2M | $50.3M | $41.1M | $59.3M | $63.7M | ||||
| Liabilities And Stockholders Equity | $408.0M | $385.5M | $429.8M | $619.2M | $654.1M | $694.2M | $795.0M | $835.4M | $880.5M | $977.3M | $1.02B | $1.07B | $1.20B | $1.23B | ||||
| Liabilities | $78.8M | $86.5M | $93.3M | $88.5M | $87.6M | $91.1M | $97.4M | $98.5M | $96.6M | $157.2M | $153.6M | $190.9M | $211.9M | $207.9M | ||||
| Common Stock Value | $2.0K | $1.0K | $30.0K | $26.0K | $26.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $24.0K | $24.0K | ||||
| Assets Current | $328.2M | $282.2M | $309.2M | $450.0M | $499.8M | $534.2M | $586.9M | $606.4M | $624.4M | $659.7M | $666.8M | $625.7M | $631.1M | $834.8M | ||||
| Assets | $408.0M | $385.5M | $429.8M | $619.2M | $654.1M | $694.2M | $795.0M | $835.4M | $880.5M | $977.3M | $1.02B | $1.07B | $1.20B | $1.23B | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $201.0K | $57.0K | $158.0K | $760.0K | -$397.0K | -$404.0K | -$1.2M | -$2.4M | -$3.9M | -$10.0M | -$8.4M | -$6.6M | -$65.0K | $73.0K | ||||
| Accrued Liabilities And Other Liabilities | $29.3M | $28.0M | $31.2M | $29.0M | $25.7M | $24.9M | $29.7M | $24.8M | $22.4M | $23.6M | $21.4M | $22.7M | $25.1M | $25.6M | ||||
| Accounts Payable Current | $2.6M | $3.4M | $3.7M | $3.6M | $4.2M | $4.9M | $4.4M | $5.8M | $5.7M | $4.8M | $4.2M | $6.5M | $3.5M | $4.9M | ||||
| Non Cash Lease Income Expense | $710.0K | $373.0K | $293.0K | $214.0K | -$1.0M | |||||||||||||
| Cash Received For Amounts Related To Tenant Improvement Allowances | $0.00 | $2.0M | $2.1M | |||||||||||||||
| Success Payment Liabilities Current | $907.0K | $1.0M | $2.5M | $1.0M | $3.8M | $2.6M | $11.7M | $9.2M | $5.6M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $41.8M | $33.1M | $47.1M | $81.9M | $62.2M | $33.3M | $15.7M |
| Proceeds From Stock Options Exercised | $42.0K | $154.0K | $306.0K | $9.6M | $9.4M | $373.0K | $0.00 |
| Proceeds From Sale And Maturity Of Available For Sale Securities | $374.7M | $548.9M | $663.6M | $419.1M | $617.4M | $686.3M | $238.5M |
| Payments To Acquire Property Plant And Equipment | $780.0K | $464.0K | $2.7M | $24.3M | $65.5M | $51.5M | $16.0M |
| Payments To Acquire Available For Sale Securities Debt | $278.9M | $394.7M | $476.9M | $406.3M | $673.5M | $864.9M | $610.8M |
| Net Cash Provided By Used In Operating Activities | -$150.0M | -$162.4M | -$163.7M | -$169.6M | -$126.2M | -$160.9M | $39.5M |
| Net Cash Provided By Used In Investing Activities | $54.1M | $122.4M | $184.0M | -$11.5M | -$121.6M | -$273.5M | -$422.4M |
| Net Cash Provided By Used In Financing Activities | $50.4M | $1.3M | $1.7M | $10.6M | $401.2M | $476.8M | $351.2M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$2.8M | -$1.8M | -$3.1M | $2.0M | $7.0M | $1.4M | $5.8M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$7.6M | -$1.3M | -$719.0K | -$463.0K | $4.5M | $6.1M | $9.8M |
| Increase Decrease In Accounts Payable | -$2.3M | -$3.2M | $1.5M | $667.0K | $91.0K | -$278.0K | $1.7M |
| Depreciation Depletion And Amortization | $11.5M | $19.6M | $20.3M | $18.0M | $13.6M | $4.3M | $1.3M |
| Increase Decrease In Other Noncurrent Liabilities | -$2.7M | -$411.0K | -$449.0K | -$453.0K | $3.7M | $0.00 | $0.00 |
| Proceeds From Stock Plans | $365.0K | $1.2M | $1.9M | $1.5M | $0.00 | $0.00 | |
| Payments Related To Tax Withholding For Share Based Compensation | $1.0K | $76.0K | $457.0K | $461.0K | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Share Based Compensation | $6.0M | $9.2M | $13.9M | $22.0M | $12.7M |
| Proceeds From Stock Options Exercised | $0.00 | $103.0K | $0.00 | $2.6M | $884.0K |
| Proceeds From Sale And Maturity Of Available For Sale Securities | $154.1M | $130.0M | $142.2M | $79.8M | $204.2M |
| Payments To Acquire Property Plant And Equipment | $246.0K | $30.0K | $1.5M | $9.7M | $19.2M |
| Payments To Acquire Available For Sale Securities Debt | $84.4M | $108.0M | $108.6M | $96.2M | $48.3M |
| Net Cash Provided By Used In Operating Activities | -$54.7M | -$42.0M | -$46.2M | -$47.9M | -$33.6M |
| Net Cash Provided By Used In Investing Activities | $69.5M | $22.0M | $32.2M | -$26.1M | $136.7M |
| Net Cash Provided By Used In Financing Activities | $1.0K | $27.0K | -$69.0K | $2.6M | $884.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$2.0M | -$595.0K | $408.0K | $397.0K | $342.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$9.8M | -$3.6M | -$5.9M | -$6.4M | -$4.7M |
| Increase Decrease In Accounts Payable | -$1.7M | -$113.0K | $2.1M | $2.9M | $634.0K |
| Depreciation Depletion And Amortization | $3.4M | $5.0M | $5.0M | $4.2M | $2.0M |
| Increase Decrease In Other Noncurrent Liabilities | -$112.0K | -$113.0K | -$112.0K | -$113.0K | $0.00 |
| Proceeds From Stock Plans | |||||
| Payments Related To Tax Withholding For Share Based Compensation | $76.0K | $69.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$16.06 | -$26.23 | -$18.70 | -$0.74 | -$1.84 | -$15.69 | -$24.04 |
| Weighted Average Number Of Shares Outstanding Basic | 17.1M | 13.1M | 12.5M | 247.1M | 135.9M | 13.3M | 5.4K |
| Weighted Average Number Of Diluted Shares Outstanding | 17.1M | 13.1M | 12.5M | 247.1M | 135.9M | 13.3M | 5.4K |
| Earnings Per Share Basic | $-16.06 | $-26.23 | $-18.70 | $-0.74 | $-1.84 | $-15.69 | $-24.04 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock Shares Outstanding | 21.3M | 14.7M | 254.0M | 249.6M | 242.7M | 15.6M | |
| Common Stock Shares Issued | 21.3M | 14.7M | 254.0M | 249.6M | 242.7M | 15.6M | |
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 264.9M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$2.13 | -$2.89 | -$0.18 | -$3.48 | -$3.59 | -$0.24 | -$0.20 | -$0.26 | -$0.27 | -$0.28 | -$0.15 | -$0.28 | -$0.20 | -$1.47 | -$3.19 | -$2.57 | -$8.18 | |
| Weighted Average Number Of Shares Outstanding Basic | 18.3M | 14.8M | 295.1M | 12.8M | 12.8M | 254.3M | 251.3M | 250.2M | 249.6M | 248.3M | 246.3M | 244.2M | 239.4M | 42.7M | 17.3M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 18.3M | 14.8M | 295.1M | 12.8M | 12.8M | 254.3M | 251.3M | 250.2M | 249.6M | 248.3M | 246.3M | 244.2M | 239.4M | 42.7M | 17.3M | |||
| Earnings Per Share Basic | $-2.13 | $-2.89 | $-0.18 | $-3.48 | $-3.59 | $-0.24 | $-0.20 | $-0.26 | $-0.27 | $-0.28 | $-0.15 | $-0.28 | $-0.20 | $-1.47 | $-3.19 | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Common Stock Shares Outstanding | 19.3M | 14.8M | 295.3M | 256.6M | 255.9M | 254.9M | 251.9M | 251.0M | 249.6M | 249.2M | 247.1M | 245.4M | 239.8M | 238.5M | ||||
| Common Stock Shares Issued | 19.3M | 14.8M | 295.3M | 256.6M | 255.9M | 254.9M | 251.9M | 251.0M | 249.6M | 249.2M | 247.1M | 245.4M | 239.8M | 238.5M | ||||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $41.8M | $33.1M | $47.1M | $81.9M | $62.2M | $33.3M | |
| Other Operating Income Expense Net | $2.1M | $3.3M | $2.8M | $4.8M | $2.3M | $9.4M | $0.00 |
| Stock Issued During Period Value Stock Options Exercised | $42.0K | $154.0K | $306.0K | $9.6M | $9.4M | $373.0K | |
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $144.0K | $29.0K | $1.3M | $4.6M | $12.7M | $3.2M |
| Additional Paid In Capital | $1.87B | $1.73B | $1.66B | $1.61B | $1.52B | $41.4M | |
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | -$1.0K | -$76.0K | -$457.0K | -$461.0K | |||
| Stock Issued During Period Value Employee Stock Purchase Plan | $365.0K | $1.2M | $1.9M | $1.5M | |||
| Fair Value Adjustment Of Warrants | $0.00 | $0.00 | $1.1M | $256.0K | -$1.3M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $5.2M | $5.0M | $6.0M | $7.6M | $8.3M | $9.2M | $10.5M | $14.2M | $13.9M | $19.1M | $22.4M | $22.0M | $13.0M | $15.2M | $12.7M | $9.8M | $7.3M |
| Other Operating Income Expense Net | $1.6M | -$1.1M | $119.0K | $730.0K | $976.0K | $1.1M | $292.0K | $569.0K | $1.3M | $1.3M | $1.2M | $1.1M | $758.0K | $223.0K | $545.0K | ||
| Stock Issued During Period Value Stock Options Exercised | $52.0K | $103.0K | $72.0K | $83.0K | $5.1M | $1.6M | $2.6M | $529.0K | $630.0K | $884.0K | |||||||
| Capital Expenditures Incurred But Not Yet Paid | $155.0K | $220.0K | $395.0K | $107.0K | $13.5M | ||||||||||||
| Additional Paid In Capital | $1.81B | $1.74B | $1.73B | $1.68B | $1.68B | $1.67B | $1.65B | $1.64B | $1.62B | $1.59B | $1.57B | $1.54B | |||||
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | $1.0K | -$76.0K | -$215.0K | -$50.0K | -$69.0K | -$367.0K | |||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $183.0K | $810.0K | $1.2M | $887.0K | |||||||||||||
| Fair Value Adjustment Of Warrants | $0.00 | -$28.0K | $43.0K |
Most recent annual filing with the SEC: March 12, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.